Get startedLog in
    Picture of Sensorion SA logo

    ALSEN — Sensorion SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Sensorion Completes Patient Inclusion In Phase 2A Clinical Trial Of SENS-401 For Residual Hearing Preservation

    Picture of Sensorion SA logoSensorion SA
    01/02/2024 06:33
    Feb 1 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION ANNOUNCES THE COMPLETION OF PATIENT INCLUSION IN
PHASE
2A CLINICAL TRIAL OF SENS-401 FOR RESIDUAL HEARING PRESERVATION
AFTER COCHLEAR IMPLANTATION

Source text for Eikon:  ID:nBw58Xcmra 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Sensorion SA

    See all news